All episodes
Targeting the Right Proteins to Treat Neurological Diseases
A Treat Locally, Act Globally Strategy for Treating Cancer
Squeezing New Possibilities into Cell Therapies
Industry Calls for New Incentives to Spur Development of New Antibiotics
Company Seeks to Prove Marine-Derived Alzheimer’s Drug Is No Fish Story
Targeting the Plasma Proteome to Address Diseases of Aging
Teaching Scientists to Be Effective Communicators
Designing Small-Molecule, Immuno-Oncology Drugs That Act Like Biologics
Biohacking for the Masses
A Hearts and Minds Strategy for Cardiovascular Disease
A Drug Hunter Finds Greater Freedom at a Nonprofit Institute
Attacking IBD Through a Novel Pathway
Writing the Future of Drug Research with Bioink
An Effort to Develop Safer and More Effective Immunotherapies
The Year in Biotech and What to Watch in 2019
Why One Investor Is Betting on Platform Technologies to Change the World
Price Transparency and a Healthcare Policy Analyst’s Brush with the Healthcare System
How a Leading Health Sciences University is Working to Address Homelessness
Gecko Looks to Broad Applications in Tissue Reconstruction
The Search for Mediators of Aging
Using Drug Delivery Technology to Improve ADHD Therapies
How One Company Is Targeting a Growing Opportunity in Women’s Reproductive Health
Why an HIV Drug in Development Could Change How Cancer Is Treated
How the Rise of the Patient-Consumer Is Changing Clinical Trials
Bringing Real-World Monitoring to Autoimmune Disease
Using Real-World Evidence to Improve Drug Development
Enlisting Immunotherapies in the Fight Against Infectious Diseases
Tackling the Problem of Resistance in Chemotherapy
Engineering Bacteria for Therapeutic Benefit
The Promise of Organ-on-a-Chip Technology to Improve Drug Development
Harnessing AI to Fight Diseases of Aging
Transforming Clinical Trials with Digital Health Technologies
Why Foresite Capital is Betting Big on the Convergence of AI and Biotech
Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events
Predicting the Unpredictable Off-Target Activities of Drugs
Why Clinics Providing Stem Cell Therapies not Approved by the FDA Are Creating Growing Concern
Making Biomedical Discoveries Sooner
Reinventing Drug Discovery with AI
Carrying Therapeutic Payloads Across the Blood-Brain Barrier
Harnessing Bacteria to Improve Skin Health
How One Accelerator Tries to Give Early-Stage Drug Developers an Edge
Making Synthetic Biology a Commercial Reality
Why Behavioral Economics May Turn Irrational Patients Rational
Pushing the Frontiers of Longevity
Is Hearing Loss a Necessary Price for Children to Pay for Life-Saving Chemotherapies
Why Diagnostics May Be Critical to Reshaping Alzheimer’s Drug Development
Why the Diversity of Genomic Data Matters
Why Biomarkers May Be the Key to Immuno-Oncology Success
Seeing Virtue in Patients
When Science Becomes a Cause
The Pursuit of Healthier, Safer, and More Humane Meat
A Hidden Killer and Why Patients Face Barriers to Accessing Promising New Drugs for It
Targeting the Regulators of Genes to Treat Disease
Price-Fixing Case Against Generic Drugmakers Widens
Outcomes Erode for Newborns and Mothers in Rural America as Hospitals Lose Obstectric Services
Why Drug Companies May Soon Become Health Technology Companies
After Facing Death, Former HR Director Helps Others Get a New Perspective on Life
Putting Physics to Work in the Fight Against Cancer
Why Aging Might Best Be Thought of as a Disease
Looking for a Better Alternative to Chemotherapy for AL Amyloidosis
A University Spin-Out that Incubates University Spin Outs
Understanding the Challenges and Opportunities of Patient-Centric Outcomes
How CellMax Hopes to Change the Diagnosis Cancer with Inexpensive Liquid Biopsy
How Surveillance and Data Are Bringing Precision to the Treatment of Prostate Cancer
Why Life Sciences M&A Should Heat up This Year
The Outlook for Biotech in 2018
The Year in Biotech and What to Watch in 2018
The Year in Immuno-Oncology and What to Watch in 2018
What the Approval of the First Digital Pill Means for the Future of Healthcare
Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events
Former CDC Director Takes on World’s Leading Cause of Death
How a Public-Private Consortium Is Revolutionizing Cancer Drug Discovery
How Faulty Thinking Can Derail Life Sciences M&A Deals
Targeting Drug-Resistant Bacteria with an Ancient Enemy
A Bioelectronic Approach to Treating Autoimmune Diseases
Harnessing Patient Data to Improve Drug Development Efficiency
How Colorifix Is Trying to Turn the Textile Industry Green
Targeting Patients as Sick as Dogs
A Strategic Investor’s View of the Biotech Investment Landscape
Bringing Gender Diversity into Biotech Boardrooms
Why the FDA May Need to Rethink Its Approach to Gene and Cell Therapy
VBL Targets Brain and other Cancers with Novel Immunotherapy
What Will It Take to Transform Healthcare to a System Focused on Prediction and Prevention
Can a Direct Pitch to Patients Drive a Home Run for Obesity Drug
Why Companies Across Industries Need to Develop a Bio Strategy
Economist Argues Maximizing Shareholder Value Hurts Drug Innovation
Partnership Drives Development of Antibiotic to Combat Resistant Gonorrhea
CIRM-Funded Pipeline of Regenerative Therapies Advances
Technology Allows Drugmakers to Tag and Authenticate Individual Pills
Harnessing Mosquitoes to Fight the Spread of Infectious Disease
Biotech Industry Moves Towards a Patent Cliff
PvP Takes a Unique Approach to Treating an Autoimmune Disease
Uncertainty Hangs over the Biotech Sector
What Others Can Learn from COI’s Approach to Cost-Efficient Drug Development
Dyadic Seek to Bring Disruptive Technology to Biomanufacturing
Enlisting the Immune System in the Battle Against Alzheimer’s
Overcoming the Delivery Challenges of Gene Therapy
Brexit Sparks Battle to House the EMA
New Safety Concerns Identified After FDA Approval of One in Three Drugs
Why Climate Change Is a Public Health Concern